Last $28.49 USD
Change Today +0.38 / 1.35%
Volume 328.5K
SGNT On Other Exchanges
Symbol
Exchange
Berlin
As of 4:00 PM 11/20/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for sagent pharmaceuticals inc (SGNT)

Year over year, Sagent Pharmaceuticals, Inc. has been able to grow revenues from $183.6M USD to $244.8M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 83.06% to 68.31%. This was a driver that led to a bottom line growth from a loss of $16.8M USD to a gain of $29.6M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues74.1152.4183.6244.8
TOTAL REVENUES74.1152.4183.6244.8
Cost of Goods Sold65.0133.6152.5167.2
GROSS PROFIT9.018.831.177.6
Selling General & Admin Expenses, Total18.925.130.136.2
R&D Expenses11.212.816.319.8
OTHER OPERATING EXPENSES, TOTAL30.237.946.456.0
OPERATING INCOME-21.1-19.1-15.321.6
Interest Expense-1.1-4.2-1.6-0.9
Interest and Investment Income0.00.30.20.0
NET INTEREST EXPENSE-1.1-3.9-1.3-0.9
Income (Loss) on Equity Investments-1.5-2.51.32.4
Other Non-Operating Income (Expenses)---0.8----
EBT, EXCLUDING UNUSUAL ITEMS-23.7-26.4-15.323.1
Merger & Restructuring Charges-------0.5
Gain (Loss) on Sale of Investments------2.9
Other Unusual Items, Total-0.8---1.55.0
Other Unusual Items-0.8---1.55.0
EBT, INCLUDING UNUSUAL ITEMS-24.5-26.4-16.830.5
Income Tax Expense------0.9
Earnings from Continuing Operations-24.5-26.4-16.829.6
NET INCOME-24.5-26.4-16.829.6
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-24.5-26.4-16.829.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-24.5-26.4-16.829.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGNT:US $28.49 USD +0.38

SGNT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lannett Co Inc $46.55 USD -0.29
OraSure Technologies Inc $8.71 USD +0.04
Pfizer Ltd/India 1,671 INR -28.15
SciClone Pharmaceuticals Inc $8.68 USD +0.135
Sucampo Pharmaceuticals Inc $11.71 USD -0.01
View Industry Companies
 

Industry Analysis

SGNT

Industry Average

Valuation SGNT Industry Range
Price/Earnings 69.6x
Price/Sales 3.4x
Price/Book 3.7x
Price/Cash Flow 67.9x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAGENT PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.